BIOMAT Database Logo BIOMAT Database Logo

[Choleragen-anatoxin chemical cholera vaccine enriched with Ogawa O-antigen]. 1984

M N Dzhaparidze, and G P Nikitina, and V L Kulikova, and A A Popov, and A V Naumov

The cultural fluid of Vibrio cholerae strains of serovar Ogawa, grown under the conditions of submerged cultivation, has been shown to contain a large amount of soluble O-antigen which sharply differs from all other concomitant components in its molecular weight. By enriching the commercial chemical cholera vaccine known as Choleragen Toxoid with purified Ogawa O-antigen a new preparation, consisting mainly of cholera toxoid and Ogawa and Inaba O-antigens and capable of producing pronounced immunity to V. cholerae of both serovars, has been obtained.

UI MeSH Term Description Entries
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D002772 Cholera Toxin An ENTEROTOXIN from VIBRIO CHOLERAE. It consists of two major protomers, the heavy (H) or A subunit and the B protomer which consists of 5 light (L) or B subunits. The catalytic A subunit is proteolytically cleaved into fragments A1 and A2. The A1 fragment is a MONO(ADP-RIBOSE) TRANSFERASE. The B protomer binds cholera toxin to intestinal epithelial cells and facilitates the uptake of the A1 fragment. The A1 catalyzed transfer of ADP-RIBOSE to the alpha subunits of heterotrimeric G PROTEINS activates the production of CYCLIC AMP. Increased levels of cyclic AMP are thought to modulate release of fluid and electrolytes from intestinal crypt cells. Cholera Toxin A,Cholera Toxin B,Cholera Toxin Protomer A,Cholera Toxin Protomer B,Cholera Toxin Subunit A,Cholera Toxin Subunit B,Choleragen,Choleragenoid,Cholera Enterotoxin CT,Cholera Exotoxin,Cholera Toxin A Subunit,Cholera Toxin B Subunit,Procholeragenoid,Enterotoxin CT, Cholera,Exotoxin, Cholera,Toxin A, Cholera,Toxin B, Cholera,Toxin, Cholera
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000907 Antibodies, Bacterial Immunoglobulins produced in a response to BACTERIAL ANTIGENS. Bacterial Antibodies
D000942 Antigens, Bacterial Substances elaborated by bacteria that have antigenic activity. Bacterial Antigen,Bacterial Antigens,Antigen, Bacterial
D000992 Antitoxins Antisera from immunized animals that is purified and used as a passive immunizing agent against specific BACTERIAL TOXINS. Antitoxin
D001428 Bacterial Vaccines Suspensions of attenuated or killed bacteria administered for the prevention or treatment of infectious bacterial disease. Bacterial Vaccine,Bacterin,Vaccine, Bacterial,Vaccines, Bacterial
D012995 Solubility The ability of a substance to be dissolved, i.e. to form a solution with another substance. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Solubilities
D014734 Vibrio cholerae The etiologic agent of CHOLERA. Bacillus cholerae,Bacillus cholerae-asiaticae,Liquidivibrio cholerae,Microspira comma,Pacinia cholerae-asiaticae,Spirillum cholerae,Spirillum cholerae-asiaticae,Vibrio albensis,Vibrio cholera,Vibrio cholerae-asiaticae,Vibrio comma

Related Publications

M N Dzhaparidze, and G P Nikitina, and V L Kulikova, and A A Popov, and A V Naumov
[The population composition of cultures of Vibrio cholerae strain 569 B Pakistan in relation to the manufacture of a cholera vaccine (choleragen-anatoxin+O-antigen)].
August 1988, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
M N Dzhaparidze, and G P Nikitina, and V L Kulikova, and A A Popov, and A V Naumov
Cholera enterotoxin (choleragen).
January 1985, Pharmacology & therapeutics,
M N Dzhaparidze, and G P Nikitina, and V L Kulikova, and A A Popov, and A V Naumov
The first British reference preparations of cholera vaccine (Inaba) and of cholera vaccine (Ogawa).
January 1977, Journal of biological standardization,
M N Dzhaparidze, and G P Nikitina, and V L Kulikova, and A A Popov, and A V Naumov
[Reactogenicity and immunological effectiveness of a chemical sorbed typhoid vaccine in combination with choleragen-anatoxin administered subcutaneously by jet injector].
February 1984, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
M N Dzhaparidze, and G P Nikitina, and V L Kulikova, and A A Popov, and A V Naumov
Studies on the partial structure of the O-antigen of Vibrio cholera Ogawa G-2102.
October 1983, Carbohydrate research,
M N Dzhaparidze, and G P Nikitina, and V L Kulikova, and A A Popov, and A V Naumov
[Standardization of chemical cholerogen-toxoid cholera vaccine according to the content of somatic O-antigen].
April 1977, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
M N Dzhaparidze, and G P Nikitina, and V L Kulikova, and A A Popov, and A V Naumov
Evaluation in mice of a conjugate vaccine for cholera made from Vibrio cholerae O1 (Ogawa) O-specific polysaccharide.
February 2014, PLoS neglected tropical diseases,
M N Dzhaparidze, and G P Nikitina, and V L Kulikova, and A A Popov, and A V Naumov
[Study of the immunogenicity and immunological effectiveness of choleragen anatoxin (data from a controlled epidemiological experiment). II. The cahracterisitcs of choleragen anatoxin immunogenicity compared with corpuscular cholera vaccines administered by syringe and by using a jet injector].
November 1974, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
M N Dzhaparidze, and G P Nikitina, and V L Kulikova, and A A Popov, and A V Naumov
Choleragen (cholera toxin): a bacterial lectin.
April 1979, Proceedings of the National Academy of Sciences of the United States of America,
M N Dzhaparidze, and G P Nikitina, and V L Kulikova, and A A Popov, and A V Naumov
[Study of the immunogenicity and immunological effectiveness of choleragen anatoxin (data from a controlled epidemiological experiment). I. The characteristics of choleragen anatoxin compared wiht corpuscular cholera vaccines administered by syringe and by using a jet injector].
November 1974, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
Copied contents to your clipboard!